Cynthia Yu‐Wai‐Man

Author

Cynthia Yu‐Wai‐Man

Also Known As

C Y Yu Wai Man, C Yu Wai Man, C. Yu-Wai-Man, C. Yu‐Wai‐Man, C.Y. Yu Wai Man, Cynthia Yu Wai Man, Cynthia Yu-Wai-Man, Cynthia Yu‐Wai‐Man, Yu-Wai-Man, Cynthia

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

University College London National Institute for Health Research Moorfields Eye Hospital NHS Foundation Trust Edge Hill University King's College London

About

Cynthia Yu‐Wai‐Man is an author at University College London specializing in ophthalmology, medicine, and engineering.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	488
2	Engineering	2	2	59
3	Natural Sciences	1	1	244
4	Social Sciences	1	1	52
5	Biomedical Engineering	1	1	29

Cynthia Yu‐Wai‐Man

Publications

Citations

H-Index

Page 1

	Year	Citations
Mutant POLG2 Disrupts DNA Polymerase γ Subunits and Causes Progressive External Ophthalmoplegia Matthew J. Longley, Susanna Clark, Cynthia Yu‐Wai‐Man, The American Journal of Human Genetics Ocular DiseaseOphthalmologyNatural SciencesDna ReplicationMolecular Biology	2006	244
Visual outcome after open globe injury: a comparison of two prognostic models—the Ocular Trauma Score and the Classification and Regression Tree Cynthia Yu‐Wai‐Man, David Steel Eye OphthalmologyRegression TreeOpen Globe InjuryTrauma SurgeryVisual Outcome	2009	142
The Effect of Cryoprotectants and Storage Conditions on the Transfection Efficiency, Stability, and Safety of Lipid‐Based Nanoparticles for mRNA and DNA Delivery Konstantinos N. Kafetzis, Natalia Papalamprou, Elisha McNulty, Advanced Healthcare Materials	2023	69
Local delivery of novel MRTF/SRF inhibitors prevents scar tissue formation in a preclinical model of fibrosis Cynthia Yu‐Wai‐Man, Bradley Spencer‐Dene, Richard M. H. Lee, Scientific Reports	2017	64
One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: a multicentre analysis Alexander Tanner, Fadi Haddad, Julia Fajardo-Sanchez, British Journal of Ophthalmology	2022	58
Receptor-targeted liposome-peptide-siRNA nanoparticles represent an efficient delivery system for MRTF silencing in conjunctival fibrosis Cynthia Yu‐Wai‐Man, Aristides D. Tagalakis, Maria Manunta, Scientific Reports	2016	57
Optic neuropathies – Importance of spatial distribution of mitochondria as well as function Cynthia Yu‐Wai‐Man, Patrick F. Chinnery, Philip G. Griffiths Medical Hypotheses Neurodegenerative DiseasesOphthalmologyNeurophysiologyNeuroanatomySpatial Distribution	2005	52
Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery Owen Fernando, Aristides D. Tagalakis, Sahar Awwad, Molecular Therapy	2018	50
In vitro and in vivo delivery of a sustained release nanocarrier-based formulation of an MRTF/SRF inhibitor in conjunctival fibrosis Aristides D. Tagalakis, Shivam Madaan, Scott D. Larsen, Journal of Nanobiotechnology	2018	40
Novel PEGylated Lipid Nanoparticles Have a High Encapsulation Efficiency and Effectively Deliver MRTF-B siRNA in Conjunctival Fibroblasts Amisha Sanghani, Konstantinos N. Kafetzis, Yusuke Sato, Pharmaceutics	2021	37

Page 1